We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$246M
AUM Growth
-$8.32M
Cap. Flow
+$6.35M
Cap. Flow %
2.58%
Top 10 Hldgs %
46.09%
Holding
106
New
14
Increased
20
Reduced
56
Closed
9

Top Buys

Rank Stock Value
1
CTNM
Contineum Therapeutics
CTNM
+$12.9M
2
CVS icon
CVS Health
CVS
+$2.44M
3
BNTX icon
BioNTech
BNTX
+$2.17M
4
EVH icon
Evolent Health
EVH
+$2.15M
5
SYK icon
Stryker
SYK
+$2.12M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$2.67M
2
PODD icon
Insulet
PODD
+$1.94M
3
EYPT icon
EyePoint Inc
EYPT
+$1.91M
4
ATEC icon
Alphatec Holdings
ATEC
+$1.88M
5
LLY icon
Eli Lilly
LLY
+$1.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLD
26
Boundless Bio
BOLD
$55.7M
$2.64M 1.07%
682,274
-173,601
-20% -$1.66M
MRNA icon
27
Moderna
MRNA
$21.8B
$2.63M 1.07%
22,110
+7,370
+50% +$933K
PCVX icon
28
Vaxcyte
PCVX
$7.65B
$2.55M 1.04%
33,730
+25,230
+297% +$1.72M
ICLR icon
29
Icon
ICLR
$14B
$2.52M 1.02%
8,028
+85
+1% +$26.6K
ELV icon
30
Elevance Health
ELV
$81.9B
$2.44M 0.99%
4,500
+1,000
+29% +$529K
ISRG icon
31
Intuitive Surgical
ISRG
$127B
$2.4M 0.98%
5,400
-700
-11% -$279K
CVS icon
32
CVS Health
CVS
$136B
$2.3M 0.94%
+39,000
New +$2.44M
BNTX icon
33
BioNTech
BNTX
$23.6B
$2.19M 0.89%
27,265
+23,740
+673% +$2.17M
FOLD
34
DELISTED
Amicus Therapeutics
FOLD
$2.15M 0.87%
216,844
-4,200
-2% -$43.1K
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.65B
$2.13M 0.87%
13,496
-3,795
-22% -$488K
GDRX icon
36
GoodRx Holdings
GDRX
$1.11B
$2.07M 0.84%
265,000
-56,000
-17% -$415K
SPRY icon
37
ARS Pharmaceuticals
SPRY
$567M
$2.02M 0.82%
236,937
+32,500
+16% +$288K
PGNY icon
38
Progyny
PGNY
$2.47B
$2M 0.81%
70,000
-6,000
-8% -$181K
CYTK icon
39
Cytokinetics
CYTK
$10.7B
$2M 0.81%
36,883
-5,700
-13% -$344K
NARI
40
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.95M 0.79%
40,500
-12,000
-23% -$532K
OPCH icon
41
Option Care Health
OPCH
$3.79B
$1.8M 0.73%
65,000
+1,000
+2% +$29.8K
HUM icon
42
Humana
HUM
$42.9B
$1.78M 0.72%
4,751
– –
AZN icon
43
AstraZeneca
AZN
$269B
$1.69M 0.69%
10,825
-1,390
-11% -$209K
STVN icon
44
Stevanato
STVN
$5.67B
$1.63M 0.66%
+89,000
New +$2.07M
EVH icon
45
Evolent Health
EVH
$385M
$1.61M 0.65%
+84,000
New +$2.15M
PODD icon
46
Insulet
PODD
$11.8B
$1.48M 0.6%
7,350
-10,750
-59% -$1.94M
EW icon
47
Edwards Lifesciences
EW
$49.3B
$1.45M 0.59%
15,650
– –
ITOS
48
DELISTED
iTeos Therapeutics
ITOS
$1.44M 0.58%
96,966
-37,000
-28% -$530K
BIIB icon
49
Biogen
BIIB
$30.6B
$1.42M 0.58%
6,137
-830
-12% -$180K
TSBX
50
DELISTED
Turnstone Biologics
TSBX
$1.36M 0.55%
517,648
– –
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sectoral Asset Management held 106 positions worth $246M, down 3.3% from $254M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sectoral Asset Management's Q2 2024 filing shows 14 new, 20 increased, 56 reduced and 9 closed positions. Its largest new stake was Contineum Therapeutics: 800,887 shares worth $14.1M. The largest sale was Centene, an estimated $2.67M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sectoral Asset Management's largest Q2 2024 buy was Contineum Therapeutics: 800,887 shares worth $14.1M.
  • Sectoral Asset Management added most to BioNTech in Q2 2024, an estimated $2.17M increase.
  • Sectoral Asset Management's biggest Q2 2024 reduction was Insulet, cutting an estimated $1.94M.
  • Sectoral Asset Management fully exited Centene in Q2 2024, selling an estimated $2.67M.
  • Sectoral Asset Management's ten largest holdings make up 46% of its $246M portfolio in Q2 2024.
  • Sectoral Asset Management opened 14 new positions and closed 9 in Q2 2024.
  • Sectoral Asset Management's portfolio value fell 3.3% quarter-over-quarter to $246M.

Based on Sectoral Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.